Analytical Data
-
Gene name
Thy1/CD90
- Application
-
Alternative Names
Thy1; CDw90; THY mocyte differentiation antigen 1
-
Species
Rat
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 95% as determined by reducing SDS-PAGE.
-
Uniprot
P01830
-
Expression Region
Met1~Leu161
-
Molecular Weight
16kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Thy1, also known as CD90, is a glycoprotein that plays a crucial role in cell adhesion, differentiation, and immune response. It is primarily expressed on the surface of various cell types, including T lymphocytes, neurons, and fibroblasts, making it an important marker in both immune and nervous system research. The study of Thy1/CD90 recombinant proteins has gained significant attention due to their potential applications in regenerative medicine, stem cell research, and immunotherapy. By generating recombinant Thy1/CD90 proteins, researchers aim to explore their effects on cell behavior, understand signaling pathways involved in immune modulation, and identify their role in promoting tissue repair and regeneration. Furthermore, these studies can help elucidate the mechanisms underlying Thy1/CD90 interactions with other cell surface molecules, enhancing the understanding of its functional relevance in various biological contexts. Given its significance, there is a growing interest in developing targeted therapies that utilize Thy1/CD90 as a therapeutic target or biomarker in diseases such as cancer and autoimmune disorders. Thus, the exploration of Thy1/CD90 recombinant proteins represents a promising avenue for advancing both fundamental biological research and clinical applications.
